Microbial riboflavin inhibits ceramide synthase 3 to lower ceramide (d18:1/26:0) and delay colorectal cancer progression

Ruize Qu(Peking University), Lulu Sun(Soochow University), Qing Yang(Guangzhou University of Chinese Medicine), Yanli Pang(Peking University), Wei Fu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yuhong Luo(Guangxi University), Xiaoting Yu(National Cancer Institute), Yang Chen(Guangzhou University of Chinese Medicine), Kristopher W. Krausz(National Institutes of Health), Jinkun Xu(Peking University), Frank J. Gonzalez(National Cancer Institute), Ying Huang(Linyi University), Guangyi Zeng(Peking University), Weike Shaoyong(Zhejiang University), Ping Wang(Netherlands Heart Registration), Yi Zhang(Pennsylvania State University), Kai Wang(Harvard University), Pengcheng Wang(University of Pittsburgh), Bora Kim(National Cancer Institute), Xin Zhou(Shandong Sport University), Jun Lin(Ruijin Hospital), Zhipeng Zhang(Ocean University of China), Siyi Lu(Peking University), Yanpeng Ma(Peking University), Weng Jing(Peking University), Shogo Takahashi(Japan Advanced Institute of Science and Technology), Tianpei Hong(Peking University)
Cell Metabolism
July 2, 2025
Cited by 20


Related Papers